Balance Sheet

v3.20.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Current assets:    
Cash $ 47 $ 433
Accounts receivable 19 28
Inventories 143 123
Prepaid expenses 7
Total current assets 209 591
Equipment, net 342 313
Operating lease right-of-use asset 723 333
Deposits 64 34
Total assets 1,338 1,271
Current liabilities:    
Accounts payable and accrued expenses 128 74
Notes payable 48 56
Deferred revenue, license agreement 20 33
Operating lease liabilities, short-term 163 86
Convertible note payable (net of discount of $225) 236 57
Derivative liabilities 680 400
Total current liabilities 1,275 706
Long term liabilities    
Deferred revenue, licenses agreement, long-term 40 34
Operating lease liabilities, long-term 567 252
Total liabilities 1,882 992
Stockholders' equity (deficit)    
Preferred stock, $0.001 par value; 25,000,000 shares authorized; non issued or outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 54,198,366 and 49,087,255 shares issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 55 49
Shares to be issued (2,943,519 and 7,318,519 as of March 31, 2020 and December 31, 2019, respectively) 2,774 2,848
Additional paid-in capital 6,224 5,620
Accumulated deficit (9,597) (8,238)
Total stockholders' equity (544) 279
Total liabilities and stockholders' equity $ 1,338 $ 1,271

Source